References
1. Antonarakis SE, Lyle R, Dermitzakis ET, Reymond A, Deutsch S.
Chromosome 21 and down syndrome: from genomics to pathophysiology.Nat Rev Genet. 2004;5(10):725-738.
2. Loane M, Morris JK, Addor MC, et al. Twenty-year trends in the
prevalence of Down syndrome and other trisomies in Europe: impact of
maternal age and prenatal screening. Eur J Hum Genet.2013;21(1):27-33.
3. de Groot-van der Mooren MD, Tamminga S, Oepkes D, Weijerman ME,
Cornel MC. Older mothers and increased impact of prenatal screening:
stable livebirth prevalence of trisomy 21 in the Netherlands for the
period 2000-2013. Eur J Hum Genet. 2018;26(2):157-165.
4. Rodman R, Pine HS. The otolaryngologist’s approach to the patient
with Down syndrome. Otolaryngol Clin North Am.2012;45(3):599-629, vii-viii.
5. Hamilton J, Yaneza MM, Clement WA, Kubba H. The prevalence of airway
problems in children with Down’s syndrome. Int J Pediatr
Otorhinolaryngol. 2016;81:1-4.
6. Stoll C, Dott B, Alembik Y, Roth MP. Associated congenital anomalies
among cases with Down syndrome. Eur J Med Genet.2015;58(12):674-680.
7. Maris M, Verhulst S, Wojciechowski M, Van de Heyning P, Boudewyns A.
Prevalence of Obstructive Sleep Apnea in Children with Down Syndrome.Sleep. 2016;39(3):699-704.
8. Lee CF, Lee CH, Hsueh WY, Lin MT, Kang KT. Prevalence of Obstructive
Sleep Apnea in Children With Down Syndrome: A Meta-Analysis. J
Clin Sleep Med. 2018;14(5):867-875.
9. Beckhaus AA, Castro-Rodriguez JA. Down Syndrome and the Risk of
Severe RSV Infection: A Meta-analysis. Pediatrics. 2018;142(3).
10. Ram G, Chinen J. Infections and immunodeficiency in Down syndrome.Clin Exp Immunol. 2011;164(1):9-16.
11. Galleguillos C, Galleguillos B, Larios G, Menchaca G, Bont L,
Castro-Rodriguez JA. Down’s syndrome is a risk factor for severe lower
respiratory tract infection due to respiratory syncytial virus.Acta Paediatr. 2016;105(11):e531-e535.
12. Goffinski A, Stanley MA, Shepherd N, et al. Obstructive sleep apnea
in young infants with Down syndrome evaluated in a Down syndrome
specialty clinic. Am J Med Genet A. 2015;167A(2):324-330.
13. Chamseddin BH, Johnson RF, Mitchell RB. Obstructive Sleep Apnea in
Children with Down Syndrome: Demographic, Clinical, and Polysomnographic
Features. Otolaryngol Head Neck Surg. 2019;160(1):150-157.
14. Pandit C, Fitzgerald DA. Respiratory problems in children with Down
syndrome. J Paediatr Child Health. 2012;48(3):E147-152.
15. Kaditis AG. Management of sleep-disordered breathing in children
with complex disorders: One size does not fit all. Pediatr
Pulmonol. 2018;53(10):1333-1335.
16. Alsubie HS, Rosen D. The evaluation and management of respiratory
disease in children with Down syndrome (DS). Paediatr Respir Rev.2018;26:49-54.
17. Horne RS, Wijayaratne P, Nixon GM, Walter LM. Sleep and sleep
disordered breathing in children with down syndrome: Effects on
behaviour, neurocognition and the cardiovascular system. Sleep Med
Rev. 2019;44:1-11.
18. Marcus CL, Moore RH, Rosen CL, et al. A randomized trial of
adenotonsillectomy for childhood sleep apnea. N Engl J Med.2013;368(25):2366-2376.
19. Best J, Mutchnick S, Ida J, Billings KR. Trends in management of
obstructive sleep apnea in pediatric patients with Down syndrome.Int J Pediatr Otorhinolaryngol. 2018;110:1-5.
20. Dudoignon B, Amaddeo A, Frapin A, et al. Obstructive sleep apnea in
Down syndrome: Benefits of surgery and noninvasive respiratory support.Am J Med Genet A. 2017;173(8):2074-2080.
21. Farhood Z, Isley JW, Ong AA, et al. Adenotonsillectomy outcomes in
patients with Down syndrome and obstructive sleep apnea.Laryngoscope. 2017;127(6):1465-1470.
22. da Rocha M, Ferraz RCM, Guo Chen V, Antonio Moreira G, Raimundo
Fujita R. Clinical variables determining the success of
adenotonsillectomy in children with Down syndrome. Int J Pediatr
Otorhinolaryngol. 2017;102:148-153.
23. Trucco F, Chatwin M, Semple T, Rosenthal M, Bush A, Tan HL. Sleep
disordered breathing and ventilatory support in children with Down
syndrome. Pediatr Pulmonol. 2018;53(10):1414-1421.
24. Simpson R, Oyekan AA, Ehsan Z, Ingram DG. Obstructive sleep apnea in
patients with Down syndrome: current perspectives. Nat Sci Sleep.2018;10:287-293.
25. Trois MS, Capone GT, Lutz JA, et al. Obstructive sleep apnea in
adults with Down syndrome. J Clin Sleep Med. 2009;5(4):317-323.
26. Hawkins A, Langton-Hewer S, Henderson J, Tulloh RM. Management of
pulmonary hypertension in Down syndrome. Eur J Pediatr.2011;170(7):915-921.
27. Maris M, Verhulst S, Wojciechowski M, Van de Heyning P, Boudewyns A.
Sleep problems and obstructive sleep apnea in children with down
syndrome, an overwiew. Int J Pediatr Otorhinolaryngol.2016;82:12-15.
28. Berry RB, Budhiraja R, Gottlieb DJ, et al. Rules for scoring
respiratory events in sleep: update of the 2007 AASM Manual for the
Scoring of Sleep and Associated Events. Deliberations of the Sleep Apnea
Definitions Task Force of the American Academy of Sleep Medicine.J Clin Sleep Med. 2012;8(5):597-619.
29. Berry RB, Gamaldo CE, Harding SM, et al. AASM Scoring Manual Version
2.2 Updates: New Chapters for Scoring Infant Sleep Staging and Home
Sleep Apnea Testing. J Clin Sleep Med. 2015;11(11):1253-1254.
30. Farrell L, Cox DW. Outpatient initiation of non-invasive ventilation
in children. Pediatr Pulmonol. 2019;54(1):10.
31. Brooks LJ, Olsen MN, Bacevice AM, Beebe A, Konstantinopoulou S,
Taylor HG. Relationship between sleep, sleep apnea, and
neuropsychological function in children with Down syndrome. Sleep
Breath. 2015;19(1):197-204.
32. Mansell SK, Cutts S, Hackney I, et al. Using domiciliary
non-invasive ventilator data downloads to inform clinical
decision-making to optimise ventilation delivery and patient compliance.BMJ Open Respir Res. 2018;5(1):e000238.
33. Zhu K, Rabec C, Gonzalez-Bermejo J, et al. Combined effects of
leaks, respiratory system properties and upper airway patency on the
performance of home ventilators: a bench study. BMC Pulm Med.2017;17(1):145.
34. Piper AJ. Advances in non-invasive positive airway pressure
technology. Respirology. 2019.
35. Maris M, Verhulst S, Wojciechowski M, Van de Heyning P, Boudewyns A.
Outcome of adenotonsillectomy in children with Down syndrome and
obstructive sleep apnoea. Arch Dis Child. 2017;102(4):331-336.
36. Sanders E, Hill CM, Evans HJ, Tuffrey C. The Development of a
Screening Questionnaire for Obstructive Sleep Apnea in Children with
Down Syndrome. Front Psychiatry. 2015;6:147.
37. Lagan N, Huggard D, Mc Grane F, et al. Multiorgan involvement and
management in children with Down Syndrome. Acta Paediatr. 2020.
38. Bull MJ, Committee on G. Health supervision for children with Down
syndrome. Pediatrics. 2011;128(2):393-406.
39. Wray J, Waters S, Radley-Smith R, Sensky T. Adherence in adolescents
and young adults following heart or heart-lung transplantation.Pediatr Transplant. 2006;10(6):694-700.
40. Menahem S, Halasz G. Parental non-compliance–a paediatric
dilemma. A medical and psychodynamic perspective. Child Care
Health Dev. 2000;26(1):61-72.
41. Santer M, Ring N, Yardley L, Geraghty AW, Wyke S. Treatment
non-adherence in pediatric long-term medical conditions: systematic
review and synthesis of qualitative studies of caregivers’ views.BMC Pediatr. 2014;14:63.
42. Killian MO, Schuman DL, Mayersohn GS, Triplett KN. Psychosocial
predictors of medication non-adherence in pediatric organ
transplantation: A systematic review. Pediatr Transplant.2018;22(4):e13188.
43. Machaalani R, Evans CA, Waters KA. Objective adherence to positive
airway pressure therapy in an Australian paediatric cohort. Sleep
Breath. 2016;20(4):1327-1336.
44. Shikama M, Nakagami G, Noguchi H, Mori T, Sanada H. Development of
Personalized Fitting Device With 3-Dimensional Solution for Prevention
of NIV Oronasal Mask-Related Pressure Ulcers. Respir Care.2018;63(8):1024-1032.